(A) Unstapled WT and mutant BID BH3 peptides. Residues highlighted in
black are conserved in most BH3-only proteins. Mutations are color coded. B,
norleucine.
(B) Cartoon-surface representation of BID BH3 bound to BOK, modeled
based on the alignment of BOK NMR structure over the BID BH3-BAK complex
(2m5b.pdb). Residues in BID were mutated according to the substitutions in (A).
BOK residues that participate in binding have been labeled.
(C) Combined average and SE of AUC at 32 min for WT PR4CA-CH in the
presence of unstapled WT and mutant BID BH3 peptides for the normalized LUVP in
Figure S5D.
(D) Combined average and SE of AUC at 32 min for WT and mutant BID BH3
peptides alone (Figure
S5D).
(E) Overlay of 1H-15N TROSY spectra of
15N-labeled G35A PR3CA titration with WT and mutant BID BH3 at
303 K and pH 6.8.
(F) CSPs plotted against concentration for indicated residues were
fitted to a hyperbola to determine the KD for the interaction of G35A
PR3CA and the WT BID BH3 peptide. Mutant BID BH3 peptides exhibited weaker
binding to BOK compared to the WT.
See also Figure
S5.